- 1. Avenacy announces the launch of five injectable antibiotic products in the U.S. market
- (Innovations)
- Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched a suite of antibiotic products for injection. Ampicillin for Injection, ...
- 2. Are we prescribing antibiotics wrong?
- (Articles)
- The message has always been clear: make sure to finish your full course of antibiotics. Or else? Risk the development of antibiotic resistance - a one-way street with no way back, which leads to one of ...
- 3. Bruker Enhances Fast, Cost-effective Hospital Hygiene Testing and HAI Tracing with IR Biotyper® by Adding NGS Reflex Testing
- (Press Releases)
- ... example, further insights into the spreading of antibiotic resistances.” Dr. Wolfgang Pusch, President of Bruker´s Microbiology & Infection Diagnostics Division, added: “Since the introduction of our ...
- 4. Imbed Biosciences receives FDA 510(k) clearance for Microlyte® Ag/Lidocaine wound dressing
- (Press Releases)
- ... of wound infections, this dressing could provide temporary pain relief in some of the most painful wounds, potentially reducing the need for both systemic antibiotics and opioids. This is a major breakthrough ...
- 5. SK bioscience Exports Influenza Vaccine to Thailand
- (Press Releases)
- ... vaccine, SKYCellflu® is safe for people who are allergic to eggs and does not require antibiotic or preservative administration. Furthermore, it is more suitable for rapid production in response to pandemics. ...
- 6. Artilysin® - A Groundbreaking "Green Pharma” Solutio
- (News)
- ... target resistant pathogens while minimizing environmental, wastewater, and food chain impact. A major concern with antibiotics is the global crisis of antibiotic resistance, severely impacting public ...
- 7. Ondine Biomedical’s Nasal Photodisinfection Reduces Hospital Length of Stay
- (News)
- One of Canada’s top research hospitals, The Ottawa Hospital, has presented results from its 2022 quality improvement study into patient outcomes after spinal surgery when using nasal photodisinfection ...
- 8. Harrow Announces Availability of Fortisite™ Formulations for In-Office Use
- (Press Releases)
- ... ImprimisRx® 503B outsourcing facility. Fortisite formulations are patent-pending high-concentration, refrigeration-stable, fortified antibiotic formulations, in solution. The availability of Fortisite ...
- 9. Pharmaceutics Conference 2023
- (Events)
- Global Conference on Pharmaceutical Science, Antibiotics, Vaccines and Drug Research “Pharmaceutics Conference 2023” going to be held on March 18-19, 2023 | Dubai, United Arab. Emirates to bring together ...